The summary below is from the full report titled “The Cost-Effectiveness of Treating All Patients with Type 2 Diabetes with Angiotensin-Converting Enzyme Inhibitors.” It is in the 2 November 1999 issue of Annals of Internal Medicine (volume 131, pages 660-667). The authors are L. Golan, J.D. Birkmeyer, and H.G. Welch.
The Costs of Preventing Kidney Failure in People with Diabetes. Ann Intern Med. 1999;131:660. doi: https://doi.org/10.7326/0003-4819-131-9-199911020-00036
Download citation file:
Published: Ann Intern Med. 1999;131(9):660.
Cardiology, Coronary Risk Factors, Diabetes, Diabetic Nephropathy, Endocrine and Metabolism.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use